Wall Street Analysts Bullish on TriSalus Life Sciences and GeoVax Labs: Buy Ratings and Price Targets Announced

Top Wall Street analysts have issued Buy ratings and price targets for two promising biotech companies, TriSalus Life Sciences (TLSI) and GeoVax Labs (GOVX). Analyst Jason Wittes of Roth MKM initiated coverage on TriSalus with a Buy rating and a $11 price target, while James Molloy of Alliance Global Partners gave GeoVax Labs a Buy rating and a $15 price target. These optimistic assessments could signal exciting times ahead for both companies.

Scroll to Top